Porphyromonas gingivalis outside the oral cavity
- PMID: 34410562
- DOI: 10.1007/s10266-021-00647-8
Porphyromonas gingivalis outside the oral cavity
Abstract
Porphyromonas gingivalis, a Gram-negative anaerobic bacillus present in periodontal disease, is considered one of the major pathogens in periodontitis. A literature search for English original studies, case series and review articles published up to December 2019 was performed using the MEDLINE, PubMed and GoogleScholar databases, with the search terms "Porphyromonas gingivalis" AND the potentially associated condition or systemic disease Abstracts and full text articles were used to make a review of published research literature on P. gingivalis outside the oral cavity. The main points of interest of this narrative review were: (i) a potential direct action of the bacterium and not the systemic effects of the inflammatory acute-phase response induced by the periodontitis, (ii) the presence of the bacterium (viable or not) in the organ, or (iii) the presence of its virulence factors. Virulence factors (gingipains, capsule, fimbriae, hemagglutinins, lipopolysaccharide, hemolysin, iron uptake transporters, toxic outer membrane blebs/vesicles, and DNA) associated with P. gingivalis can deregulate certain functions in humans, particularly host immune systems, and cause various local and systemic pathologies. The most recent studies linking P. gingivalis to systemic diseases were discussed, remembering particularly the molecular mechanisms involved in different infections, including cerebral, cardiovascular, pulmonary, bone, digestive and peri-natal infections. Recent involvement of P. gingivalis in neurological diseases has been demonstrated. P. gingivalis modulates cellular homeostasis and increases markers of inflammation. It is also a factor in the oxidative stress involved in beta-amyloid production.
Keywords: Bone; Brain; Cardiovascular; Gingipain; Lung; Porphyromonas gingivalis; Systemic disease; Virulence factor.
© 2021. The Society of The Nippon Dental University.
Similar articles
-
Molecular Strategies Underlying Porphyromonas gingivalis Virulence.J Mol Biol. 2021 Apr 2;433(7):166836. doi: 10.1016/j.jmb.2021.166836. Epub 2021 Feb 1. J Mol Biol. 2021. PMID: 33539891 Review.
-
Pathogenesis of Important Virulence Factors of Porphyromonas gingivalis via Toll-Like Receptors.Front Cell Infect Microbiol. 2019 Jul 18;9:262. doi: 10.3389/fcimb.2019.00262. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31380305 Free PMC article. Review.
-
The role of gingipains in the pathogenesis of periodontal disease.J Periodontol. 2003 Jan;74(1):111-8. doi: 10.1902/jop.2003.74.1.111. J Periodontol. 2003. PMID: 12593605 Review.
-
Host cell-surface proteins as substrates of gingipains, the main proteases of Porphyromonas gingivalis.Biol Chem. 2018 Nov 27;399(12):1353-1361. doi: 10.1515/hsz-2018-0215. Biol Chem. 2018. PMID: 29927743 Review.
-
Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor.Adv Exp Med Biol. 1996;389:155-64. doi: 10.1007/978-1-4613-0335-0_19. Adv Exp Med Biol. 1996. PMID: 8861006
Cited by
-
Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease.Ann Med. 2023;55(2):2255825. doi: 10.1080/07853890.2023.2255825. Ann Med. 2023. PMID: 37708866 Free PMC article. Review.
-
How Periodontitis or Periodontal Bacteria Can Influence Alzheimer's Disease Features? A Systematic Review of Pre-Clinical Studies.J Alzheimers Dis. 2023;96(3):979-1010. doi: 10.3233/JAD-230478. J Alzheimers Dis. 2023. PMID: 37927257 Free PMC article.
-
Use of Biomaterials in 3D Printing as a Solution to Microbial Infections in Arthroplasty and Osseous Reconstruction.Biomimetics (Basel). 2024 Mar 1;9(3):154. doi: 10.3390/biomimetics9030154. Biomimetics (Basel). 2024. PMID: 38534839 Free PMC article. Review.
-
Oral Pathogenic Bacteria and the Oral-Gut-Liver Axis: A New Understanding of Chronic Liver Diseases.Diagnostics (Basel). 2023 Oct 26;13(21):3324. doi: 10.3390/diagnostics13213324. Diagnostics (Basel). 2023. PMID: 37958220 Free PMC article. Review.
-
Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis.Front Med (Lausanne). 2022 Mar 2;9:822190. doi: 10.3389/fmed.2022.822190. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35308549 Free PMC article. Review.
References
-
- Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, Mealey BL, Papapanou PN, Sanz M, Tonetti MS. A new classification scheme for periodontal and peri-implant diseases and conditions—introduction and key changes from the 1999 classification. J Periodontol. 2018;89(Suppl 1):S1–8. https://doi.org/10.1002/JPER.18-0157 . - DOI - PubMed
-
- Bernardi S, Karygianni L, Filippi A, Anderson AC, Zurcher A, Hellwig E, Vach K, Macchiarelli G, Al-Ahmad A. Combining culture and culture-independent methods reveals new microbial composition of halitosis patients’ tongue biofilm. Microbiologyopen. 2020;9: e958. https://doi.org/10.1002/mbo3.958 . - DOI - PubMed
-
- Polak D, Ferdman O, Houri-Haddad Y. Porphyromonas gingivalis capsule-mediated coaggregation as a virulence factor in mixed infection with Fusobacterium nucleatum. J Periodontol. 2017;88:502–10. https://doi.org/10.1902/jop.2016.160397 . - DOI - PubMed
-
- Brunner J, Scheres N, El Idrissi NB, Deng DM, Laine ML, van Winkelhoff AJ, Crielaard W. The capsule of Porphyromonas gingivalis reduces the immune response of human gingival fibroblasts. BMC Microbiol. 2010;10:5. https://doi.org/10.1186/1471-2180-10-5 . - DOI - PubMed - PMC
-
- Singh A, Wyant T, Anaya-Bergman C, Aduse-Opoku J, Brunner J, Laine ML, Curtis MA, Lewis JP. The capsule of Porphyromonas gingivalis leads to a reduction in the host inflammatory response, evasion of phagocytosis, and increase in virulence. Infect Immun. 2011;79:4533–42. https://doi.org/10.1128/IAI.05016-11 . - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources